TTK Healthcare Limited (NSE:TTKHLTCARE)

Market Cap	13.61B -17.0%
Revenue (ttm)	9.18B +11.3%
Net Income	2.77B +317.3%
EPS	195.70 +317.3%
Shares Out	n/a
PE Ratio	4.90
Forward PE	n/a
Dividend	10.00 (1.04%)
Ex-Dividend Date	Jul 17, 2026

Volume	9,349
Open	930.10
Previous Close	927.55
Day's Range	930.10 - 964.80
52-Week Range	735.00 - 1,247.00
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Foods, Protective Devices and Other segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment i...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1928
• Employees: 1,384
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TTKHLTCARE

Financial Performance

In fiscal year 2026, TTK Healthcare's revenue was 8.57 billion, an increase of 6.96% compared to the previous year's 8.01 billion. Earnings were 656.81 million, a decrease of -19.57%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error